Induction of thyroid papillary carcinoma cell proliferation by estrogen is associated with an altered expression of Bcl-xL

Cancer Journal

Volumn 11, Issue 2, 2005, Pages 113-121

  Lee, M L ^a   Chen, G G ^a   Vlantis, A C ^a   Tse, G M K ^a   Leung, B C H ^a   Van Hasselt, C A ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Bcl xL; Estradiol; Proliferation; Testosterone; Thyroid papillary carcinoma

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL XL; TAMOXIFEN; TESTOSTERONE; BCL2L1 PROTEIN, HUMAN; PROTEIN BCL 2; PROTEIN BCL X; STEROID RECEPTOR;

ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID PAPILLARY CARCINOMA; WESTERN BLOTTING; DRUG EFFECT; FEMALE; GENE EXPRESSION PROFILING; GENETICS; IN VITRO STUDY; MALE; METABOLISM; PAPILLARY CARCINOMA; SEX DIFFERENCE; THYROID TUMOR; UNITED STATES;

BCL-X PROTEIN; BLOTTING, WESTERN; CARCINOMA, PAPILLARY; CELL PROLIFERATION; ESTROGENS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, ESTROGEN; RECEPTORS, STEROID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEX FACTORS; TESTOSTERONE; THYROID NEOPLASMS; UNITED STATES;

EID: 23944435017     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/00130404-200503000-00006     Document Type: Article

References (33)

1. Correa P, Chen VW. Endocrine gland cancer. Cancer 1995;75:338-352.
2. Ron E, Kleinerman RA, Boice JD et al. A population-based case-control study of thyroid cancer. J Natl Cancer Inst 1987;79:1-12.
3. Hiasa Y, Nishioka H, Kitahori Y et al. Immunohistochemical analysis of estrogen receptors in 313 paraffin section cases of human thyroid tissue. Oncology 1993;50:132-136.
4. Dalla Valle L, Ramina A, Vianello S et al. Potential for estrogen synthesis and action in human normal and neoplastic thyroid tissues. J Clin Endocrinol Metab 1998;83:3702-3709.
5. Bonacci R, Pinchera A, Fierabracci P et al. Relevance of estrogen and progesterone receptors enzyme immunoassay in malignant, benign and surrounding normal thyroid tissue. J Endocrinol Invest 1996;19:159-164.
6. Kawabata W, Suzuki T, Moriya T et al. Estrogen receptors (alpha and beta) and 17beta-hydroxysteroid dehydrogenase type 1 and 2 in thyroid disorders: possible in situ estrogen synthesis and actions. Mod Pathol 2003;16:437-444.
7. Christoph H, Marion L, Alexandra B et al. Differential mechanisms of neuroprotection by 17 beta-estradiol in apoptotic versus necrotic neurodegeneration. J Neurosci 2001;21:2600-2609.
8. Pelzer T, Schumann M, Neumann M et al. 17 beta-estradiol prevents programmed cell death in cardiac myocytes. Biochem Biophys Res Commun 2000;268:192-200.
9. Wang TTY, Phang JM. Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7. Cancer Res 1995;55:2487-2489.
10. Bu SZ, Yin DL, Ren XH et al. Progesterone induces apoptosis and up-regulation of p53 expression in human ovarian carcinoma cell lines. Cancer 1997;79:1944-1950.
11. Manole D, Schildknecht B, Gosnell B et al. Estrogen promotes growth of human thyroid tumor cells by different molecular mechanisms. J Clin Endocrinol Metab 2001;86:1072-1077.
12. Fagin JA. Molecular pathogenesis of tumors of thyroid follicular cells. In: Fagin JA, ed. Thyroid Cancer. Boston: Kluwer, 1998:59-84.
13. Gao Z, Matsuo H, Nakago S et al. p53 tumor suppressor protein content in human uterine leiomyomas and its down-regulation by 17beta-estradiol. J Clin Endocrinol Metab 2002;87:3915-3920.
14. Franke HR, Kole S, Ciftci Z et al. In vitro effects of estradiol, hydrogesterone, tamoxifen and cyclophosphamide on proliferation vs. death in human breast cancer cells. Cancer Lett 2002;190:113-118.
15. Choi KC, Kang SK, Tai CJ et al. Estradiol up-regulates antiapoptotic Bcl-2 messenger ribonucleic acid and protein in tumorigenic ovarian surface epithelium cells. Endocrinology 2000;142:2351-2360.
16. Inoue H, Oshimo K, Miki H et al. Immunohistochemical study of estrogen receptors and the responsiveness to estrogen in papillary thyroid carcinoma. Cancer 1993;72:1364-1368.
17. Yane K, Kitahori Y, Konishi N et al. Expression of the estrogen receptor in human thyroid neoplasms. Cancer Lett 1994;84:59-66.
18. Clark OH, Gerend PL, Davis M et al. Estrogen and thyroid-stimulating hormone (TSH) receptors in neoplastic and nonneoplastic human thyroid tissue. J Surg Res 1985;38:89-96.
19. Yu M, Lin JD, Giuliano AE et al. Estrogen and progesterone receptor expression and E-2 regulated cell proliferation in four human thyroid cancer cell lines. Thyroidol Clin Exp 1996;8:79-86.
20. Pace P, Taylor J, Suntharalingam S et al. Human estrogen receptor binds in a manner similar to and dimerizes with estrogen receptor. J Biol Chem 1997;272:25832-25838.
21. Petterson K, Grandien K, Kuiper G et al. Mouse estrogen receptor beta forms estrogen response element-binding heterodimers with estrogen receptor alpha. Mol Endocrinol 1997;11:1486-1496.
22. Chao DT, Korameyer S. Bcl-2 family: regulators of cell death. Annu Rev Immunol 1998;16:395-419.
23. Perillo B, Sasso A, Abbondanza C et al. 17β-Estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence. Mol Cell Biol 2000;20:2890-2901.
24. Pike CJ. Estrogen modulates neuronal Bcl-xL expression and beta-amyloid-induced apoptosis: relevance to Alzheimer's disease. J Neurochem 1999;72:1552-1563.
25. Leung LK, Wang TT. Paradoxical regulation of bcl-2 family proteins by 17-estradiol in human breast cancer cells MCF-7. Br J Cancer 1999;81:387-392.
26. Kelly MJ, Lagrange AH, Wagner EJ et al. Rapid effects of estrogen to modulate G protein-coupled receptors via activation of protein kinase A and protein kinase C pathways. Steroids 1999;64:64-75.
27. Sun M, Paciga JE, Feldman RI et al. Phosphatidylinositol-3-OH Kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor alpha (ERalpha) via interaction between ERalpha and PI3K. Cancer Res 2001;61:5985-5991.
28. Santen R, Jeng MH, Wang JP et al. Adaptive hypersensitivity to estradiol: potential mechanism for secondary hormonal responses in breast cancer patients. J Steroid Biochem Mol Biol 2001;79:115-125.
29. Chen Q, Hung FC, Fromm L et al. Induction of cell cycle entry and cell death in postmitotic lens fiber cells by overexpression of E2F1 or E2F2. Invest Ophthalmol Vis Sci 2000;41:4223-4231.
30. Cobb MH. MAP kinase pathways. Prog Biophys Mol Biol 1999;71:479-500.
31. Prendergast GC. Mechanisms of apoptosis by c-Myc. Oncogene 1999;18:2967-2987.
32. Bacus SS, Gudkov AV, Lowe M et al. Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53. Oncogene 2001;20:147-155.
33. Evan G, Littlewood T. A matter of life and cell death. Science 1998;281:1317-1322.